Research Alliance Corp III
RACC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002118032
No open-market purchases or sales by Research Alliance Corp III insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $79.6M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Research Alliance Corp III as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +23 vs. Q1 2026
- Shares held
- 7.43M
- +7.43M vs. Q1 2026
- Total value
- $79.6M
- +$79.6M vs. Q1 2026
- New holders
- 23
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RACC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $79.6M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Research Alliance Corp III; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 750,000 | $8.03M | 0.12% | +750,000 | New |
| ADAR1 Capital Management, LLC | 650,000 | $6.96M | 0.33% | +650,000 | New |
| BVF Inc | 500,000 | $5.35M | 0.14% | +500,000 | New |
| Balyasny Asset Management LLC | 500,000 | $5.35M | 0.01% | +500,000 | New |
| Commodore Capital LP | 500,000 | $5.35M | 0.32% | +500,000 | New |
| TCG Crossover Management, LLC | 500,000 | $5.35M | 0.13% | +500,000 | New |
| Spruce Street Capital LP | 500,000 | $5.35M | 1.05% | +500,000 | New |
| Trails Edge Capital Partners, LP | 500,000 | $5.35M | 0.85% | +500,000 | New |
| Jupiter Topco LLC | 400,000 | $4.37M | 0.00% | +400,000 | New |
| Braidwell LP | 400,000 | $4.28M | 0.16% | +400,000 | New |
| Cormorant Asset Management, LP | 370,000 | $3.96M | 0.20% | +370,000 | New |
| Affinity Asset Advisors, LLC | 370,000 | $3.96M | 0.19% | +370,000 | New |
| Silverarc Capital Management, LLC | 360,000 | $3.85M | 0.43% | +360,000 | New |
| VR Adviser, LLC | 300,000 | $3.21M | 0.10% | +300,000 | New |
| Foresite Capital Management VI LLC | 300,000 | $3.21M | 0.50% | +300,000 | New |
| J. Goldman & Co LP | 177,531 | $1.90M | 0.07% | +177,531 | New |
| Toronto Dominion Bank | 146,811 | $1.57M | 0.00% | +146,811 | New |
| Logos Global Management LP | 100,000 | $1.07M | 0.05% | +100,000 | New |
| Aristeia Capital LLC | 50,000 | $535.0K | 0.01% | +50,000 | New |
| Two Sigma Investments, LP | 33,912 | $362.9K | 0.00% | +33,912 | New |
| Lineage Point Capital LP | 23,302 | $249.3K | 0.05% | +23,302 | New |
| UBS Group AG | 16 | $171 | 0.00% | +16 | New |
| Morgan Stanley | 7 | $75 | 0.00% | +7 | New |